Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

An overactive immune sensor — not just damaged DNA — may be the real culprit behind rapid aging disorders. Scientists found that a molecule called cGAS can mistake the body's own broken DNA for a viral threat, triggering chronic inflammation that destroys healthy tissue. When researchers dialed down cGAS activity in a fast-aging model, tissue function broadly improved, hinting at a new treatment approach for devastating degenerative diseases.
Researchers have long assumed that unrepaired DNA is the main driver of rapid aging disorders. But a new international study led by scientists at Hebrew University and the University of Southern California suggests the body's own immune response may be doing much of the damage.
When DNA repair systems fail — as they do in rare conditions like Ataxia-Telangiectasia (A-T) and Bloom syndrome — broken DNA fragments can leak into the wrong part of the cell. There, a molecular sensor called cGAS mistakes them for viral DNA and sounds the alarm, triggering chronic inflammation that harms healthy tissue. Compounding the problem, cGAS can also migrate into the cell nucleus and directly disrupt DNA repair, creating a destructive double hit.
When the team reduced cGAS activity in a fast-aging vertebrate model, they observed broad improvements — less neuroinflammation, less tissue degeneration, and restored reproductive capacity — suggesting the body can tolerate more DNA damage than previously thought, as long as the inflammatory response is kept in check.
Key Takeaways:
Why it matters: This research reframes how scientists think about degenerative disease — the damage isn't the whole story; the body's reaction to it is. That opens a potentially new therapeutic avenue: rather than correcting every broken strand of DNA, future treatments could target the inflammatory cascade that follows, offering hope for some of the most difficult-to-treat aging-related disorders.